The ASP committee updated the COVID guidelines. You will find the following change:
-Removal of the pre-exposure prophylaxis guidelines since monoclonal antibodies are no longer easly available.
-Clarification on the Remdesivir dosing in CKD
-CT value should not guide treatment decision in patient with COVID since it was associated with morbidity in the MUHC.
Thank you!
Francois Bourdeau
ASP committee developed a post-exposure prophylaxis (HIV, hepB & hepC) guidelines in collaboration with the CVIS team. It is available on our website! Francois Bourdeau ASP MUHC coordinator
Correction made for Heart transplant and Lung transplant recipients: both anti-mold AND anti-PJP prophylaxis recommended.
To MUHC users: Please note that as of Dec 5, 2022, requests for outpatient antiviral management of COVID-19 for HIGH RISK patients should be directed to the ID-AMB (formerly MicroB/Lachine) service ra